Steven R. Hagen, SVP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 10,500 shares at $16.06 ($169K) on 2014-11-14, disclosed to the SEC on 2014-11-18.
Seasonal sale ($169k) by SVP Pharmaceutical Development & Mfg — this insider has traded AMRI in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |